CS-4771 Phase 1 study - A randomized, double-blind, placebo-controlled, continuous IV infusion for 96 hours, ascending dose study to assess the safety, pharmacokinetics and pharmacodynamics of CS-4771 in Japanese healthy subjects -
开始日期2012-08-24
申办/合作机构-
JPRN-JapicCTI-121939
/ Unknown status临床1期
CS-4771 Phase 1 study - A randomized, double-blind, placebo-controlled, continuous IV infusion for 96 hours, ascending dose study to assess the safety, pharmacokinetics and pharmacodynamics of CS-4771 in Japanese healthy subjects -